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Abstract 
There have been many articles highlighting differences and similarities between complex regional pain 
syndrome (CRPS) and functional neurological disorders (FND) but until now the discussions have often 
been adversarial with an unhelpful focus on malingering and a view of FND as “all in the mind”. 
However, understanding of the nature, frequency and treatment of FND has changed dramatically in 
the last 10-15 years. They are no longer assumed to be only “conversion” of psychological conflict but 
are understood as a complex interplay between physiological stimulus, expectation, learning and 
attention mediated through a Bayesian framework, with biopsychosocial predisposing, triggering and 
perpetuating inputs. Building on this new ‘whole brain’ perspective of FND we reframe the debate 
about the “psychological versus physical” basis of CRPS. We recognise how CRPS research may inform 
mechanistic understanding of FND and conversely, how advances in FND, especially treatment, have 
implications for improving understanding and management of CRPS. 
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INTRODUCTION 
Complex regional pain syndrome (CRPS) is a disabling chronic pain condition that may follow physical 
injury to a limb, either through surgery or trauma. Previously, there were no clear diagnostic criteria, 
and a mixture of terminologies used, such as “Reflex Sympathetic Dystrophy (RSD)” and “Causalgia”. 
In response to this, the International Association for the Study of Pain (IASP) introduced a new 
terminology in an attempt to standardise diagnosis and management: CRPS type I- where there was 
no defined nerve lesion and type II, where there was a definite nerve lesion. These definitions have 
since been superseded by the Budapest clinical and research criteria (table 1).[1,2] CRPS occurs in 
around 20 out of 100,000 patients, with more women than men being affected, most commonly in the 
37-53 year age range. It is characterized by local inflammatory and autonomic dysregulation combined 
with trophic and motor dysfunction of the affected body part.[3] Although its defining features 
(sensory, autonomic, motor and trophic) have been extensively studied, their pathophysiological 
nature and the role of the incipient event remain a matter of debate and research.[3]  
 
Table 1: Budapest clinical diagnostic criteria for CRPS[2,3], with features also seen in functional 
neurological disorder in bold 
1. Continuing pain, which is disproportionate to any inciting event 
2. Must report at least one symptom in three of the four following categories: 
• Sensory: reports of hyperaesthesia and/or allodynia 
• Vasomotor: reports of temperature asymmetry and/or skin colour changes and/or skin 
colour asymmetry 
• Sudomotor/oedema: reports of oedema and/or sweating changes and/or sweating 
asymmetry 
• Motor/trophic: reports of decreased range of motion and/or motor dysfunction 
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
3. Must display at least one sign at time of evaluation in two or more of the following categories: 
• Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or 
deep somatic pressure and/or joint movement) 
• Vasomotor: evidence of temperature asymmetry and/or skin colour changes and/or 
asymmetry 
• Sudomotor/oedema: evidence of oedema and/or sweating changes and/or sweating 
asymmetry 
• Motor/trophic: evidence of decreased range of motion and/or motor dysfunction 
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
4. There is no other diagnosis that better explains the signs and symptoms 
 
 
In the debate surrounding CRPS one conceptual schism stands out as particularly polarizing and 
counterproductive: the role of psychological processes.[4,5] This debate has typically been 
characterised over the years as a discussion between those who see CRPS as a genuine medical 
disorder, and those who seek to define it as a ‘non-organic’ or ‘psychogenic’ disorder. Indeed it was 
classified as hysteria minor by the so-called 'father of neurology' Jean-Martin Charcot in 1892.[4,6] 
Within the umbrella of ‘non-organic’ there has often been little distinction between patients with a 
genuinely experienced functional neurological disorder (FND; also called psychogenic or conversion 
disorder) and those patients wilfully exaggerating symptoms for medical care or financial gain.[7,8] 
Voluntary feigning of CRPS signs and symptoms is rarely found in cases of malingering or factitious 
disorder[9-11] and must not be equated with FND.  
FND describes the presence of disabling and/or distressing motor and sensory symptoms which can be 
identified by the presence of positive evidence of internal inconsistency such as Hoover’s sign or 
tremor entrainment sign, or other evidence of incompatibility with a structural disease process. Such 
positive motor and sensory signs have been consistently identified as also characterising the motor 
and sensory features of CRPS. For example, there is no clinical difference between the fixed dystonia 
characterised by a clenched fist or plantarflexed/inverted ankle seen in CRPS and that seen in FND 
without pain.[12] Tremor,[13] limb weakness[14] and sensory disturbance[15] have also been 
identified as having the same features in CRPS as in FND (Table 2, figure 1). Importantly, the need for 
antecedent psychological stressors has been removed from newer diagnostic criteria in DSM-5 for FND 
in recognition that, like CRPS, many patients don’t have identifiable stressors or psychiatric 
comorbidity[16,17]. This is important, since the absence of pre-existing or comorbid psychiatric 
problems has often been falsly interpreted as evidence against functional (psychogenic) processes in 
CRPS. Concurrently, there is now a large literature on changes in brain function in patients with FND, 
including differences to feigning, which is changing previous narrow purely ‘psychogenic’ thinking 
about the disorder[18]. 
 
Table 2: Clinical overlap of Complex Regional Pain Syndrome (CRPS) and Functional Neurological 
Disorder (FND) 
 Complex Regional Pain 
Syndrome 
Functional Neurological Disorder Pathologically 
defined disease 
 
Trigger 
 
Physical injury or surgery 
 
Physical injury or surgery in 37-
80%[19] 
Dependent on 
disorder 
Sensory Loss or hyperalgesia[20] 
Non-dermatomal, dense[21], 
may be whole limb[22] or 
hemisensory[22] 
 
Common response to 
placebo[8] 
Loss or hyperalgesia[23] 
Non-dermatomal, dense, may be 
whole limb or hemisensory 
[23],[24] 
Common response to placebo[24] 
In keeping with 
expected lesion 
location 
 
Limited response to 
placebo[8] 
Movement 
Disorders 
 
 
Dystonia 
 
Combination of movement 
disorders common(dystonia, 
tremor, myoclonus)[25] 
 
Combination of movement 
disorders or other FNDs 
common[30] 
 
Rapid onset, often fixed, dystonia 
of hand or foot[31],[30] 
Unusual to have 
several different 
movement disorders 
 
 
 
 
 
Tremor 
 
 
Rapid onset, often fixed, 
dystonia of hand or 
foot[26],[27]  
Can spread to other limbs[13] 
May seek limb amputation[28] 
 
Entrainment of tremor possible 
and diminished by 
distraction[27],[25,29] 
 
Can spread to other limbs[31] 
May seek limb amputation[28,30] 
 
Entrainment of tremor possible 
and diminished or stopped by 
distraction[32] 
 
Gradual onset over 
months/years of 
mobile dystonia[15] 
Unlikely to seek 
amputation[28] 
 
Entrainment rare in 
patients with 
tremor[33] 
Weakness 
 
Give-way[14,21] 
Distribution and Hoovers sign 
not studied. 
 
 
Give-way[34] 
Global pattern of weakness with 
signs of internal inconsistency 
(e.g. Hoovers sign) 
 
Follows expected 
patterns based on 
lesion location. 
 
Description 
from 
patient 
“My mind tells my hand/foot to 
move, but it won’t 
work”.[35],[13] 
“My painful limb feels as though 
it is not part of my body”[36] 
 
Symptoms described as neglect-
like but actually involving 
increased attention and 
dissociation) 
“His left leg would sometimes 
drag behind him, accompanied by 
an odd sense that it did not 
belong to him.”[37] 
 
Common for patients to describe 
feelings of disconnection or lack 
of ownership of limbs. Usually 
interpreted as dissociative. 
Feeling of limb 
dissociation can be 
seen in some 
conditions such as 
parietal dysfunction. 
 
Neglect of limb 
involves absence of 
interest/awareness 
of limb[38]. 
Comorbid 
Functional 
Disorders 
Some evidence of excess 
comorbidity of functional 
disorders such a fibromyalgia 
although poorly studied[39][40]  
 
 
Comorbid functional disorders 
including other FND greatly in 
excess of population[41], [42] 
Functional disorders 
common in 
population, 
including those with 
disease [43,44] 
 
However, in the face of multiple indicators of central and peripheral changes in CRPS, in contrast to a 
dualistic, anachronistic and traditionally poorly articulated idea of functional disorders as exclusively 
the domain of psychological disturbance (or worse still, malingering), it is perhaps not surprising that 
polarisation has persisted.[5,45] In much of the literature it is easy to detect, and understand, a 
defensive tone in which advocates for patients with CRPS defend the integrity of their patients against 
those who would ‘doubt’ them or accuse them of having a stigmatised psychiatric disorder. 
In a review from 2000, Ronald P. Pawl concludes that "[t]here is no convincing evidence that a primary 
organic dysfunction of the nervous system, in particular the autonomic nervous system, exists in 
[CRPS]".[46] Perhaps because of the increasing evidence of neurobiological abnormalities in CRPS, a 
more recent review has diametrically opposed views: Hill and colleagues summarize that "there is no 
indication that psychological factors cause the onset of pain, autonomic dysfunction, and movement 
disorders in CRPS patients".[45] The dualistic nosological line of separation between CRPS and FND is 
drawn with such unanimous certainty that it extends well into the newest international diagnostic 
criteria, that see FND as a differential diagnosis which strictly precludes CRPS.[1,47] Lastly, this 
polarized view is perhaps best exemplified in the recent UK guidelines which was authored without 
input from either neurologists or psychiatrists: "a combination of elements including inflammation, 
dysfunction within sympathetic and somatosensory nervous system, and cortical (not psychological) 
factors are thought to contribute to the generation and perpetuation of symptoms"(emphasis 
added).[48] With a recently reinvigorated interest in functional disorders of the nervous system, 
neurologists have been reasserting the conceptual proximity and physiological overlap of FND and 
CRPS[49,50] but these have stopped short of challenging the dualistic thinking that has dogged both 
disorders. 
Most current authors on CRPS tend to acknowledge a limited (secondary) role of psychological factors, 
without considering an alternative possibility – that the conventional divide between ‘organic’ and 
‘non-organic’ disorders is no longer tenable in the face of what we know about the brain and body. 
Discarding this division allows for a new possibility: to have a disorder of nervous system functioning 
which presents with physical symptoms and which can exist independently of psychiatric comorbidity 
but in which cognitive and behavioural factors are still relevant.  
This review will re-examine the clinical overlap and common pathology of CRPS and FND and will 
propose that the debate moves in this more productive middle ground. Providing first a brief overview 
of the pathophysiology of CRPS and FND (see Figure 2), we will then go on to present a unifying 
framework for understanding these disorders and will review the implications for treatment. In doing 
so we believe that patients, clinicians and researchers in both CRPS and FND could benefit.  
 
THE OVERLAPS BETWEEN CRPS AND SENSORIMOTOR FND 
CRPS is a chronic pain disorder with a combination of sensory, motor, autonomic and dystrophic 
changes.[51] These changes are usually triggered by an incipient event such as injury or surgery, but 
can occur spontaneously in a minority of cases.[52] Although traditionally FNDs have been associated 
with psychological trauma, systematic studies have revealed that they very often arise from physical 
injury.[19,53] In a systematic review of 869 cases, 37% of functional motor and sensory disorders had 
a history of physical injury, and in surgical settings, similar to CRPS, 79% of sensorimotor FND are 
preceded by a physical precipitant.[19] In a prospective cohort of 50 patients with functional 
movement disorders (dystonia in 36%), as many as 80% reported a precipitating "physical" noxious 
event within the preceding three months, with 38% fulfilling the criteria for panic attack in association 
with said event.[53] The combination of immobilisation (reflexive due to acute pain or iatrogenic 
through plaster cast bandaging) and excessive anxiety is considered a potential precipitant for FND 
development.[53,54] Stressful life events precede FND only in about a half of cases,[16,55] and their 
importance has been downgraded from a diagnostic criterion to an optional risk factor in the revision 
of DSM-5.[56] 
Central to our argument is the nature of motor and sensory signs seen in both CRPS and FND (Table 1, 
Figure 1). In contrast to classic (idiopathic/primary) dystonia, functional dystonia is usually immobile 
("fixed"); develops acutely, often following minor injury; cannot be alleviated by sensory tricks (so-
called geste antagoniste) but is instead intensified by any manipulation; is accompanied by other 
functional motor and sensory symptoms; and is usually associated with regional pain.[57] Even in 
functional paralysis without dystonic posturing, pain in the affected limb is reported in a third of 
cases.[58] In their large series of "fixed dystonia", Schrag and colleagues reported a 20% overlap of 
CRPS.[12] Meanwhile, Mailis-Gagnon and colleagues found that among 54 presumed CRPS cases, 
experts determined 18% to be suffering from “psychogenic” disorders.[59] Limb weakness and 
bradykinesia are almost universally present in CRPS, with most having ‘give-way’ weakness.[14,21] and 
around 70% of patients develop movement disorders such as dystonic posturing, tremor and/or 
myoclonic jerks.[13,21,26,60] Patients show reduced voluntary control,[36,61] and have problems 
initiating movement[21] or assessing limb position.[62] Sensory symptoms are often in a non-
dermatomal distribution.[22] Other positive diagnostic features used in the diagnosis of FND, such as 
distractibility, suggestibility, clinical inconsistency and physiological incongruity [63,64] can be found 
in CRPS patients. 
How can the clinical overlap between FND and CRPS be understood in terms of pathophysiology? The 
early alterations seen in CRPS are dominated by peripheral inflammatory changes and autonomic 
response.[47] Local nerve injury is thought to underlie early neuropathic pain[65] and can trigger 
neurogenic tissue inflammation mediated by neuropeptides such as substance P and calcitonin gene 
related peptide (CGRP).[66] Driven also by pro-inflammatory cytokines such as TNF-a, IL-1b, IL-2 and 
IL-6, this inflammatory state is thought to underlie hyperalgesia,[67,68] early allodynia,[69] and 
autonomic and dystrophic changes.[47,70] Autonomic changes can include so-called sympatho-
afferent coupling, whereby nociceptive fibres are thought to be activated by sympathetic nervous 
system activity.[3] The neuroimmunological interplay is further complicated by the potential 
contributions of neural autoantibodies[4,71] and small noncoding RNA molecules called 
microRNA.[72] Importantly, such pro-inflammatory, autonomic and hyperalgesic regional tissue 
reactions can be observed reliably in (experimental models of) acute injury, transient immobilization 
and chronic pain in general.[73-78]  
So what keeps these pro-inflammatory processes in CRPS from abating normally over time, as they 
usually would after injury and temporary immobilisation? In CRPS, we hypothesise that the peripheral 
inflammation becomes interlocked with much wider-reaching nervous system maladaptations that are 
identical to those seen in FND (figure 2). 
A temporary adaptation of movement to acute pain (or to the expectation of pain) is a physiological 
reaction, and involves a redistribution of muscle activity that leads to stiffening, restriction and slowing 
of movement, and favours relieving postures[79]. Such adaptations, while normally only transient and 
largely under volitional control, can become entrenched in robust pathways through cycles of negative 
reinforcement until they are no longer within the reach of conscious control. Hypervigilance and 
avoidance based on anxious illness beliefs, catastrophizing tendencies, or excessive self-monitoring 
can imprint expectations of pain and immobility that can distort and even override incoming sensory 
information.[54,80] Such failure to re-adapt has been proposed to underlying chronic dysfunction in 
FND, and can just as well explain sensory and motor symptoms in chronic CRPS. 
Studies of central nervous function using functional MRI and transcranial magnetic stimulation in both 
disorders have revealed subtle but comparable abnormalities of brain activations (see Aybek & 
Vuilleumier, 2016[81], and Di Pietro et al., 2013a[82], 2013b[83], for review). Most studies examining 
central function in CRPS and FND are too heterogenous to allow direct comparisons, but there is one 
group that has tested motor execution and imagery using the same paradigm in both CRPS[84] and 
functional limb weakness ("conversion paralysis").[85] Compared to healthy controls, CRPS patients 
showed hypoactivation of the postcentral gyrus and inferior parietal cortex contralaterally during 
imagined movement of the affected hand.[84] Similarly, patients with functional limb weakness 
("conversion paralysis") showed decreased activity of the contralateral supramarginal cortex (part of 
the inferior parietal cortex) compared to controls on imagined movement in the affected hand.[85] In 
van Velzen’s study of patients with CRPS,[85] healthy controls and immobilised patients showed 
normal corticospinal activity during motor imagery and motor observation. The authors postulated 
that motor symptoms of weakness, slowness and dystonia in CRPS are due to abnormal afferent 
(peripheral) information processing and therefore treatment should be focused on normalising this by 
touch and use of the affected limb.[86] However, other neurophysiological investigation of peripheral 
mechanisms of CRPS and motor FND have demonstrated inhibition of sensorimotor integration and 
reduced corticospinal activity in motor imagery but not observation, suggesting a central mechanism 
of movement inhibition.[87-89] In all likelihood, both peripheral and central mechanisms are involved 
at different stages. 
Neuroimaging of pain states can show activation in motor areas of the brain.[90] Central pain 
hypersensitisation has been demonstrated in experimental immobilisation[91],[92] and is reflected in 
the non-dermatomal distribution of sensory symptoms in CRPS.[93] While sensory symptoms in motor 
FNDs have received woefully little attention in research so far, clinical experience shows that if inquired 
about, they will be reported by the majority person with functional weakness[58] and other functional 
movement disorder. In a cohort study of sensorimotor FND, many patients showed a fluid shift of 
symptoms over time between sensory and movement domains.[94] Interestingly, even characteristic 
autonomic changes such as regional limb temperature changes can be induced experimentally using 
protocols for disrupted sense of limb ownership (rubber hand illusion), emphasizing the influence of 
top-down processes.[95] 
Given the well-documented overlap in clinical presentation and the common pathophysiological 
pathways described above, why is CRPS considered so distinct from FND, or vice versa, and why have 
FND researchers devoted so little attention to sensory symptoms and inflammatory processes? The 
reason, we would argue, is in the historical framing and re-framing of these disorders addressed in the 
introduction. Pain specialists, decidedly impressed by the evidence of tissue changes that 
immunologists and molecular biologists have provided, have come to see top-down cognitive and 
behavioural processes as secondary effects of CRPS pathology. Of course, phobic avoidance and 
anxiety are being recognized and treated, but they are not seen as driving factors of the disorder per 
se. Similarly, neurologists, often troubled with the differentiation of organic vs. "non-organic", tend to 
see FNDs, once identified, as strictly psychogenic disorders. Sensory alterations and trophic changes 
are discarded as by-products of a unidirectional top-down disorder and receive little attention both 
clinically and in research. Thus, CRPS and FND seem to occupy opposing lanes of the highway, with all 
the same landmarks of pathology clearly visible, but, alas, never the twain shall meet. 
However, this is not how organic systems works, especially recursive neuronal networks and their 
neurohumoural and neuroimmunological continuations. Bidirectional hierarchical models based on 
Bayesian inference have recently been formulated for both FND[80] and CRPS.[96]They necessitate an 
urgent re-thinking for both disorders in which outdated ideas of "psychogenic vs. neurogenic" have to 
be shaken off permanently. "Top-down processes" do not refer to mysterious forms of subconscious 
symptom conversion. Rather, the expectation of pain will influence not just movement (kinesiophobia, 
avoidant disuse) but also pain perception itself, as any nocebo researcher will confirm.[97] 
Furthermore, these reiterative cognitive-behavioural patterns of pain expectation and pain 
perception, kinesiophobia and disuse, will imprint themselves into the neural systems that underly 
nociception and movement through synaptic and cortical plasticity, giving rise to central allodynia and 
functional limb weakness. Crucially, normalisation cannot be forced purely bottom-up through 
analgesic drugs, but has to be achieved through some form of modulation of top-down influence.  
 
TREATMENT  
Understanding CRPS and FND in this way has potential benefits for treatment of both disorders. In 
FND, there have been recent promising randomised controlled trials of physiotherapy that emphasise 
the importance of establishing the potential for reversibility in FND, often through scrutiny of the 
motor signs themselves. Conversely, FND researchers have much to learn from mechanistic and 
treatment studies in CRPS.  
In recent years there has been an evolution in how clinicians approach the explanation of FND. 
Previously patients may have been told they had a psychological problem and needed referral to a 
psychiatrist. Now many clinicians have advocated an emphasis on understanding the mechanism of 
the motor symptom itself and considering psychological comorbidities separately. Of central 
importance to this approach, and to the new DSM-5 diagnosis of FND, is to demonstrate to the patient 
the positive clinical signs, such as Hoover’s sign of functional leg weakness, when weakness of hip 
extension normalises with contralateral hip flexion, or tremor transiently abates with distraction. The 
positive signs of FND emphasize profoundly therapeutic feature of the diagnosis: that the symptoms 
are due to a functional rather than structural problem, arise from the brain (and not the limb), and 
have the potential for reversibility. This ‘software rather than hardware’ framework for the patient to 
understand how and why the disorder has occurred, with a focus on correcting abnormal self-directed 
attention and movement expectation, appears in many cases to be key to successful treatment.[98,99] 
Two randomised controlled trials of physiotherapy have shown the potential success of this approach 
in FND.[100,101] A recent trial of 60 patients randomised either to specific FND therapy or a similar 
number of community physiotherapy sessions showed significant improvement in functional 
independence and mobility scores in the treatment versus control arms (72% vs. 18%) even in patients 
with long duration of symptoms (5.8 years). Patients in the control arm only improved in 18% of cases 
and on six-month follow up 32% had developed worsening symptoms (3% in the treatment arm).[99] 
Another RCT, also of 60 patients with functional gait disorder, demonstrated the normalisation of gait 
in most patients despite a 9-month duration of symptoms.[100] More than half of the patients in 
Nielsen et al’s 2016 study had pain or fatigue described as severe or extreme.[100] Part of the 
treatment was education that the mechanisms for FND are similar to those for chronic pain, are not 
correlated with worsening structural damage, and are potentially reversible by re-training.[99] 
An updated Cochrane review of physiotherapy for patients with CRPS found some evidence of 
improvement in pain and functional disability with graded motor therapy and improvement in 
impairment one year after multimodal physiotherapy; however, evidence for both was classed as very 
low quality.[102] Perceived harmfulness of activities and pain-related fear predicts functional 
limitations in CRPS[103] and patients with CRPS have increased phobic anxiety compared with patients 
with other types of chronic pain.[104] Based on these principles, an RCT (n=46) of exposure versus 
pain-contingent treatments has demonstrating significant benefit in disability, reduced pain 
catatrophisation, pain intensity and increased physical and mental health-related quality of life at six 
months follow up.[105] Treatment for patients with chronic CRPS (average 5.1 years) involved reducing 
pain-related fear using exposure treatment with a similar paradiagm as used in the treatement of 
anxiety disorders. Another treatment series of 106 patients with ‘end stage CRPS’ who had failed other 
CRPS treaments, described outpatient physiotherapy focused on achieving movement after an 
extensive explanation of CRPS as a ‘reversible deregulation of the nervous system’ and pain as a ‘false 
warning sign’ rather than something suggesting ongoing tissue injury.[106] In these 106 patients 
function improved in 95 patients and a full functional recovery occurred in 49 (46%) despite 
medications being stopped and some increase in pain during treatment. There is a clear overlap 
between these treatment approaches for CRPS and FND which mirrors the overlap in the disorders 
themselves.  
Psychological therapy is a first line therapy for patients with dissociative seizures and has some 
evidence for functional neurological disorders in general.[107,108] Psychologists and psychiatrists play 
an important role in successful multi-disciplinary for patients with FND.[109] From our experience, the 
best outcomes in patients with motor FNDs occur when patients have treatment which challenges 
their top-down expectations, kinesiophobia and behavioural habits such as avoidance, as well as 
physical therapy improving peripheral input. The technique of formulation of the mechanism of motor 
FNDs, taken from cognitive behavioural therapy, along with self-reflection and a personalised physical 
and mental management plan for dealing with exacerbations may be the key differences between 
successful and unsuccessful physical therapy in FND.[100] 
In summary, a case series and randomised controlled trials based on communicating an understanding 
of both FND and CRPS as due to an abnormal potentially reversible malfunctioning nervous system, 
followed by physiotherapy focused on regaining function even if pain is transiently increased, have 
demonstrated positive outcomes. This suggests that patients’ understanding is key and demonstrates 
that improvement is possible even in those patients who have had CRPS or FMD for many years. In our 
view, education based physiotherapy which targets both top-down processes and expectations as well 
as bottom-up sensorimotor inputs +/- peripherally acting medication adjuncts, should be the mainstay 
of treatment for both disorders.  
 
CONCLUSION 
Discussions involving CRPS and functional disorders have been adversarial in the past. We have a new 
understanding of what functional disorders are: centrally mediated processes of abnormal self-
directed attention, often triggered by peripheral stimuli, with complex neural, emotional and social 
risk factors and perpetuation. Combining this with a removal of the suspicion of feigned symptoms 
from the conversation of what CRPS and FNDs are, leads us to a new path of learning from each 
disorder. There is significant overlap between both CRPS and FND in new mechanistic understanding, 
motor symptoms, imaging and neurophysiology studies. In both CRPS and FND, explanation-based 
physical treatment, which encompasses understanding of the disorders as reversible seems most 
positive. There is much for FND researchers to learn from the work already done into peripheral and 
central mechanism of CRPS and more attention is required for investigating “bottom-up” input into 
the mechanistic model of functional disorders. Similarly, recognising shared social, emotional and 
cognitive risk factors and bidirectional input as the method of CRPS symptom production will allow for 
more encompassing explanation and treatment strategies. We hope that presenting the similarities 
and learning from both disorders, with open acknowledgment of the antagonistic history, will 
encourage researchers in CRPS and FND to now put this to one side and collaborate and open useful 
discussions on how to understand and treat these complex and important disorders. 
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FIGURE LEGENS: 
Figure 1: Similarities in clinical features. Dystonic foot in CRPS (A,[51]) and in FND (B[110]). Typical 
distribution of sensory features in CRPS (C,[22]) and FND (D,[111]) 
Figure 2: An illustration of the pathophysiological overlap between Complex Regional Pain Syndrome 
and Functional Neurological Disorder. *"Paralysis" stands in for any form of movement disorder typical 
of CRPS such as dystonia, tremor or weakness. 
 
